Amarin Corporation

Amarin Corporation ROE

The Return on Equity (ROE) of Amarin Corporation (AMRN) as of Nov 19, 2026 is -8.45 %. In the previous year, Return on Equity (ROE) was -16.90 % — a change of -50.03% (higher).

ROE

-8.45 %

YoY

-50.03%

Last updated:

In 2025, Amarin Corporation's return on equity (ROE) was -8.45 %, a -50.03% increase from the -16.90 % ROE in the previous year.

The Amarin Corporation ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-76.44 USD
Jan 1, 2019
-3.72 USD
Jan 1, 2020
-2.87 USD
Jan 1, 2021
1.16 USD
Jan 1, 2022
-17.77 USD
Jan 1, 2023
-10.71 USD
Jan 1, 2024
-16.90 USD
Jan 1, 2025
-8.45 USD
The Amarin Corporation ROE history
YEARROEYoY
-8.45 %-50.03%
-16.90 %+57.88%
-10.71 %-39.75%
-17.77 %-1,633.93%
1.16 %-140.39%
-2.87 %-22.95%
-3.72 %-95.13%
-76.44 %-173.33%
104.25 %-89.06%
953.30 %+969.04%
89.17 %+39.93%
63.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

ROE Details

Decoding Amarin Corporation's Return on Equity (ROE)

Amarin Corporation's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Amarin Corporation's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Amarin Corporation's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Amarin Corporation’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Amarin Corporation stock

Return on Equity (ROE) of Amarin Corporation is -8.45 % in 2025.

Return on Equity (ROE) of Amarin Corporation changed from -16.90 % to -8.45 %, representing a -50.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Amarin Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Amarin Corporation

All Key Metrics — Amarin Corporation